Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Final ban for human dura mater products in France:

This article was originally published in Clinica

Executive Summary

The French government has published a final ban on the import, export and use of human dura mater products and has ordered the withdrawal of all products containing the tissue. The French health directorate issued the final of three bans following reports by the French national research body, INSERM about possible dangers from transfer of Creutzfeldt-Jakob disease and statements from medical consulting organisations that human dura mater is not irreplaceable in surgery. Costs involved in withdrawing products must be met by the manufacturer or importer.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089571

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel